Top Markets
Coin of the day
ShockWave Medical, Inc. ShockWave Medical, Inc.

ShockWave Medical, Inc.

SWAV
Rangering i aksjer #1815
ShockWave Medical, Inc. is a medical technology firm that specializes in the... ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Aksjekurs
$334.75
Sist synkronisert: 2024-05-30
Markedsverdi
$12.46B
Endring (1 dag)
-0.02%
Endring (1 år)
0.00%
Land
US
Handel ShockWave Medical, Inc. (SWAV)

Kategori

Inntekter for ShockWave Medical, Inc. (SWAV)
Inntekter i Mar 2024 TTM: $183.54M
Ifølge ShockWave Medical, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $183.54M. I 2022 hadde selskapet et resultat på $120.83M, en økning sammenlignet med resultatet i 2021, som var $-8.84M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for ShockWave Medical, Inc. fra 2017 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $183.54M 5.31%
2023 $174.28M 44.24%
2022 $120.83M -1,467.61%
2021 $-8.84M -86.54%
2020 $-65.62M 28.55%
2019 $-51.05M 24.31%
2018 $-41.06M 34.24%
2017 $-30.59M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$7.51B 3,992.23%
US
$5.15B 2,704.79%
US
$5.56B 2,930.90%
IE
$3.86B 2,003.59%
US
- -
DE